Formulation development, in-vitro and ex-vivo evaluation of dry adsorbed solid lipid nanoparticles: an approach of overcoming olanzapine drawbacks

[1] Ali Khan A, Mudassir J, Mohtar N, Darwis Y. Advanced drug delivery to the lymphatic system: lipid-based nanoformulations. Int J Nanomedicine. 2013;8:2733–2744. doi: 10.2147/IJN.S41521. Ali KhanA MudassirJ MohtarN DarwisY Advanced drug delivery to the lymphatic system: lipid-based nanoformulations Int J Nanomedicine 2013 8 2733 2744 10.2147/IJN.S41521 Open DOISearch in Google Scholar

[2] Bhalekar MR, Pokale R, Bandivadekar M, Madgulkar A, Nagore P. Self Micro-Emulsifying Drug Delivery System for Lymphatic Uptake of Darunavir. J Drug Discov Develop Deliv. 2016;3:1–7. BhalekarMR PokaleR BandivadekarM MadgulkarA NagoreP Self Micro-Emulsifying Drug Delivery System for Lymphatic Uptake of Darunavir J Drug Discov Develop Deliv 2016 3 1 7 Search in Google Scholar

[3] Bunaciu AA, Udriştioiu EG, Aboul-Enein HY. X-Ray Diffraction: Instrumentation and Applications. Crit Rev Anal Chem. 2015;45:289–299. doi: 10.1080/10408347.2014.949616. BunaciuAA UdriştioiuEG Aboul-EneinHY X-Ray Diffraction: Instrumentation and Applications Crit Rev Anal Chem 2015 45 289 299 10.1080/10408347.2014.949616 Open DOISearch in Google Scholar

[4] Bunjes H, Unruh T. Characterization of lipid nanoparticles by differential scanning calorimetry, X-ray and neutron scattering. Adv Drug Deliv Rev. 2007;59:379–402. doi: 10.1016/j.addr.2007.04.013. BunjesH UnruhT Characterization of lipid nanoparticles by differential scanning calorimetry, X-ray and neutron scattering Adv Drug Deliv Rev 2007 59 379 402 10.1016/j.addr.2007.04.013 Open DOISearch in Google Scholar

[5] Casteleyn C, Doom M, Lambrechts E, Van den Broeck W, Simoens P, Cornillie P. Locations of gut-associated lymphoid tissue in the 3-month-old chicken: a review. Avian Pathol. 2010;39:143–150. doi: 10.1080/03079451003786105. CasteleynC DoomM LambrechtsE Van den BroeckW SimoensP CornillieP Locations of gut-associated lymphoid tissue in the 3-month-old chicken: a review Avian Pathol 2010 39 143 150 10.1080/03079451003786105 Open DOISearch in Google Scholar

[6] Cavaco MC, Pereira C, Kreutzer B, et al. Evading P-glycoprotein mediated-efflux chemoresistance using Solid Lipid Nanoparticles. Eur J Pharm Biopharm. 2017;110:76–84. doi: 10.1016/j.ejpb.2016.10.024. CavacoMC PereiraC KreutzerB Evading P-glycoprotein mediated-efflux chemoresistance using Solid Lipid Nanoparticles Eur J Pharm Biopharm 2017 110 76 84 10.1016/j.ejpb.2016.10.024 Open DOISearch in Google Scholar

[7] Chiu MH, Prenner EJ. Differential scanning calorimetry: An invaluable tool for a detailed thermodynamic characterization of macromolecules and their interactions. J Pharm Bioallied Sci. 2011;3:39–59. doi: 10.4103/0975-7406.76463. ChiuMH PrennerEJ Differential scanning calorimetry: An invaluable tool for a detailed thermodynamic characterization of macromolecules and their interactions J Pharm Bioallied Sci 2011 3 39 59 10.4103/0975-7406.76463 Open DOISearch in Google Scholar

[8] Daswadkar SC, Atole AV. Formulation and Evaluation of Solid Lipid Nanoparticles of Olanzapine for the Treatment of Psychosis. J Drug Deliv Ther. 2020;10:25–3. doi: 10.22270/jddt.v10i5-s.4440. DaswadkarSC AtoleAV Formulation and Evaluation of Solid Lipid Nanoparticles of Olanzapine for the Treatment of Psychosis J Drug Deliv Ther 2020 10 25 3 10.22270/jddt.v10i5-s.4440 Open DOISearch in Google Scholar

[9] Dening TJ, Rao S, Thomas N, Prestidge CA. Oral nanomedicine approaches for the treatment of psychiatric illnesses. J Control Release. 2016;223:137–156. doi: 10.1016/j.jconrel.2015.12.047. DeningTJ RaoS ThomasN PrestidgeCA Oral nanomedicine approaches for the treatment of psychiatric illnesses J Control Release 2016 223 137 156 10.1016/j.jconrel.2015.12.047 Open DOISearch in Google Scholar

[10] Joseph E, Reddi S, Rinwa V, Balwani G, Saha R. Design and in vivo evaluation of solid lipid nanoparticulate systems of Olanzapine for acute phase schizophrenia treatment: Investigations on antipsychotic potential and adverse effects. Eur J Pharm Sci. 2017;104:315–325. doi: 10.1016/j.ejps.2017.03.050. JosephE ReddiS RinwaV BalwaniG SahaR Design and in vivo evaluation of solid lipid nanoparticulate systems of Olanzapine for acute phase schizophrenia treatment: Investigations on antipsychotic potential and adverse effects Eur J Pharm Sci 2017 104 315 325 10.1016/j.ejps.2017.03.050 Open DOISearch in Google Scholar

[11] Freitas MR, Rolim LA, Soares MF, Rolim-Neto PJ, Albuquerque MM, Soares-Sobrinho JL. Inclusion complex of methyl-β-cyclodextrin and olanzapine as potential drug delivery system for schizophrenia. Carbohydr Polym. 2012;89:1095–1100. doi: 10.1016/j.carbpol.2012.03.072. FreitasMR RolimLA SoaresMF Rolim-NetoPJ AlbuquerqueMM Soares-SobrinhoJL Inclusion complex of methyl-β-cyclodextrin and olanzapine as potential drug delivery system for schizophrenia Carbohydr Polym 2012 89 1095 1100 10.1016/j.carbpol.2012.03.072 Open DOISearch in Google Scholar

[12] Gershkovich P, Hoffman A. Uptake of lipophilic drugs by plasma derived isolated chylomicrons: linear correlation with intestinal lymphatic bioavailability. Eur J Pharm Sci. 2005;26:394–404. doi: 10.1016/j.ejps.2005.07.011. GershkovichP HoffmanA Uptake of lipophilic drugs by plasma derived isolated chylomicrons: linear correlation with intestinal lymphatic bioavailability Eur J Pharm Sci 2005 26 394 404 10.1016/j.ejps.2005.07.011 Open DOISearch in Google Scholar

[13] Gupta H, Bhandari D, Sharma A. Recent trends in oral drug delivery: a review. Recent Pat Drug Deliv Formul. 2009;3:162–173. doi: 10.2174/187221109788452267. GuptaH BhandariD SharmaA Recent trends in oral drug delivery: a review Recent Pat Drug Deliv Formul 2009 3 162 173 10.2174/187221109788452267 Open DOISearch in Google Scholar

[14] Heera P. Shanmugam S. Nanoparticle Characterization and Application : An Overview. Int. J Curr Microbiol App Sci. 2015;4:379–386. HeeraP. ShanmugamS. Nanoparticle Characterization and Application : An Overview Int. J Curr Microbiol App Sci 2015 4 379 386 Search in Google Scholar

[15] Hirlekar R, Patil E, Bhairy S. Solid nanostructured lipid carriers loaded with silymarin for oral delivery: Formulation development and evaluation. Curr Trends Pharm Pharm Chem. 2021;3:56–67. doi: 10.18231/j.ctppc.2021.014. HirlekarR PatilE BhairyS Solid nanostructured lipid carriers loaded with silymarin for oral delivery: Formulation development and evaluation Curr Trends Pharm Pharm Chem 2021 3 56 67 10.18231/j.ctppc.2021.014 Open DOISearch in Google Scholar

[16] Jawahar N, Meyyanathan SN, Senthil V, Gowthamarajan K, Elango K. Studies on physico-chemical and pharmacokinetic properties of olanzapine through nanosuspension. J Pharm Sci Res. 2013;5:196–202. JawaharN MeyyanathanSN SenthilV GowthamarajanK ElangoK Studies on physico-chemical and pharmacokinetic properties of olanzapine through nanosuspension J Pharm Sci Res 2013 5 196 202 Search in Google Scholar

[17] Jenning V, Gohla S. Comparison of wax and glyceride solid lipid nanoparticles (SLN). Int J Pharm. 2000;196:219–222. doi: 10.1016/S0378-5173(99)00426-3. JenningV GohlaS Comparison of wax and glyceride solid lipid nanoparticles (SLN) Int J Pharm 2000 196 219 222 10.1016/S0378-5173(99)00426-3 Open DOISearch in Google Scholar

[18] Kalepu S, Manthina M, Padavala V. Oral lipid-based drug delivery systems – an overview. Acta Pharm Sin B. 2013;3:361–372. doi: 10.1016/j.apsb.2013.10.001. KalepuS ManthinaM PadavalaV Oral lipid-based drug delivery systems – an overview Acta Pharm Sin B 2013 3 361 372 10.1016/j.apsb.2013.10.001 Open DOISearch in Google Scholar

[19] Kaur CD, Nahar M, Jain NK. Lymphatic targeting of zidovudine using surface-engineered liposomes. J Drug Target. 2008;16:798–805. doi: 10.1080/10611860802475688. KaurCD NaharM JainNK Lymphatic targeting of zidovudine using surface-engineered liposomes J Drug Target 2008 16 798 805 10.1080/10611860802475688 Open DOISearch in Google Scholar

[20] Koteshwara KB, Reddy MS, Naha A, Nampoothiri M. Nanosuspensions: A novel drug delivery approach. Int J Res Ayurveda Pharm. 2011;2:162–165. KoteshwaraKB ReddyMS NahaA NampoothiriM Nanosuspensions: A novel drug delivery approach Int J Res Ayurveda Pharm 2011 2 162 165 Search in Google Scholar

[21] Liversidge G, Jenkins S, Liversidge EM. Injectable nanoparticulate olanzapine formulations. U.S. Patent No. US20050274887. November 16, 2005. LiversidgeG JenkinsS LiversidgeEM Injectable nanoparticulate olanzapine formulations U.S. Patent No. US20050274887. November 16 2005 Search in Google Scholar

[22] Maheswarappa MK, Desai PD. Design and in-vitro evaluation of mouth dissolving tablets of olanzapine. Asian J Pharm. 2011;5:107–113. doi: 10.4103/0973-8398.84551. MaheswarappaMK DesaiPD Design and in-vitro evaluation of mouth dissolving tablets of olanzapine Asian J Pharm 2011 5 107 113 10.4103/0973-8398.84551 Open DOISearch in Google Scholar

[23] Makwana V, Jain R, Patel K, Nivsarkar M, Joshi A. Solid lipid nanoparticles (SLN) of Efavirenz as lymph targeting drug delivery system: Elucidation of mechanism of uptake using chylomicron flow blocking approach. Int J Pharm. 2015;495:439–446. doi: 10.1016/j.ijpharm.2015.09.014. MakwanaV JainR PatelK NivsarkarM JoshiA Solid lipid nanoparticles (SLN) of Efavirenz as lymph targeting drug delivery system: Elucidation of mechanism of uptake using chylomicron flow blocking approach Int J Pharm 2015 495 439 446 10.1016/j.ijpharm.2015.09.014 Open DOISearch in Google Scholar

[24] Millan MJ, Fone K, Steckler T, Horan WP. Negative symptoms of schizophrenia: clinical characteristics, pathophysiological substrates, experimental models and prospects for improved treatment. Eur Neuropsychopharmacol. 2014;24:645–692. doi: 10.1016/j.euroneuro.2014.03.008. MillanMJ FoneK StecklerT HoranWP Negative symptoms of schizophrenia: clinical characteristics, pathophysiological substrates, experimental models and prospects for improved treatment Eur Neuropsychopharmacol 2014 24 645 692 10.1016/j.euroneuro.2014.03.008 Open DOISearch in Google Scholar

[25] Müller RH, Mäder K, Gohla S. Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art. Eur J Pharm Biopharm. 2000;50:161–177. doi: 10.1016/s0939-6411(00)00087-4. MüllerRH MäderK GohlaS Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art Eur J Pharm Biopharm 2000 50 161 177 10.1016/s0939-6411(00)00087-4 Open DOISearch in Google Scholar

[26] Natarajan J, Baskaran M, Humtsoe LC, Vadivelan R, Justin A. Enhanced brain targeting efficacy of Olanzapine through solid lipid nanoparticles. Artif Cells Nanomed Biotechnol. 2017;45:364–371. doi: 10.3109/21691401.2016.1160402. NatarajanJ BaskaranM HumtsoeLC VadivelanR JustinA Enhanced brain targeting efficacy of Olanzapine through solid lipid nanoparticles Artif Cells Nanomed Biotechnol 2017 45 364 371 10.3109/21691401.2016.1160402 Open DOISearch in Google Scholar

[27] Patel S, Shah J, Bhairy S, Hirlekar R. Development of Curcumin loaded Nanostructured Lipid Carriers: Preparation, Characterization and Invitro Evaluation of Anti-cancer Activity Against A-549 Human Lung Cancer Cell Line. J Cancer Tumor Int. 2021;11:66–88. doi: 10.9734/JCTI/2021/v11i430162. PatelS ShahJ BhairyS HirlekarR Development of Curcumin loaded Nanostructured Lipid Carriers: Preparation, Characterization and Invitro Evaluation of Anti-cancer Activity Against A-549 Human Lung Cancer Cell Line J Cancer Tumor Int 2021 11 66 88 10.9734/JCTI/2021/v11i430162 Open DOISearch in Google Scholar

[28] Reddy RN, Shariff A. Solid lipid Nanoparticles: An advanced drug delivery system. Int J Pharm Sci Res. 2013;4:161–171. doi: 10.13040/IJPSR.0975-8232.4(1).161-71. ReddyRN ShariffA Solid lipid Nanoparticles: An advanced drug delivery system Int J Pharm Sci Res 2013 4 161 171 10.13040/IJPSR.0975-8232.4(1).161-71 Open DOISearch in Google Scholar

[29] Sarraguça MC, Cruz AV, Soares SO, Amaral HR, Costa PC, Lopes JA. Determination of flow properties of pharmaceutical powders by near infrared spectroscopy. J Pharm Biomed Anal. 2010;52:484–492. doi: 10.1016/j.jpba.2010.01.038. SarraguçaMC CruzAV SoaresSO AmaralHR CostaPC LopesJA Determination of flow properties of pharmaceutical powders by near infrared spectroscopy J Pharm Biomed Anal 2010 52 484 492 10.1016/j.jpba.2010.01.038 Open DOISearch in Google Scholar

[30] Shah J, Patel S, Bhairy S, Hirlekar R. Formulation optimization, characterization and in-vitro anti-cancer activity of curcumin loaded nanostructured lipid carriers. Int. J. Curr. Pharm. Res. 2022;14:31–43. doi: 10.22159/ijcpr.2022v14i1.44110. ShahJ PatelS BhairyS HirlekarR Formulation optimization, characterization and in-vitro anti-cancer activity of curcumin loaded nanostructured lipid carriers Int. J. Curr. Pharm. Res. 2022 14 31 43 10.22159/ijcpr.2022v14i1.44110 Open DOISearch in Google Scholar

[31] Shahhet L, Al-Raghban A, Chehna MF. Improvement of the physicochemical properties of amoxicillin trihydrate powder by recrystallization at different pH values. Int J Pharm Pharm Sci. 2011;3:92–100. ShahhetL Al-RaghbanA ChehnaMF Improvement of the physicochemical properties of amoxicillin trihydrate powder by recrystallization at different pH values Int J Pharm Pharm Sci 2011 3 92 100 Search in Google Scholar

[32] Sumeet S, Natarajan J, Kunal J, Kuppusamy G, Subramania NM. Olanzapine loaded cationic solid lipid nanoparticles for improved oral bioavailability. Curr Nanosci. 2013;9:26–34. doi: 10.2174/1573413711309010007. SumeetS NatarajanJ KunalJ KuppusamyG SubramaniaNM Olanzapine loaded cationic solid lipid nanoparticles for improved oral bioavailability Curr Nanosci 2013 9 26 34 10.2174/1573413711309010007 Open DOISearch in Google Scholar

[33] Wang JS, Taylor R, Ruan Y, Donovan JL, Markowitz JS, Lindsay De Vane C. Olanzapine penetration into brain is greater in transgenic Abcb1a P-glycoprotein-deficient mice than FVB1 (wild-type) animals. Neuropsychopharmacology. 2004;29:551–557. doi: 10.1038/sj.npp.1300372. WangJS TaylorR RuanY DonovanJL MarkowitzJS Lindsay De VaneC Olanzapine penetration into brain is greater in transgenic Abcb1a P-glycoprotein-deficient mice than FVB1 (wild-type) animals Neuropsychopharmacology 2004 29 551 557 10.1038/sj.npp.1300372 Open DOISearch in Google Scholar